OSU-CG5, a novel energy restriction mimetic agent, targets human colorectal cancer cells in vitro
El‐Shaimaa A. Arafa(Beni-Suef University), Hany A. Omar(Beni-Suef University)
Cited by 35
Related Papers
Tangeretin Alleviates Cisplatin-Induced Acute Hepatic Injury in Rats: Targeting MAPKs and Apoptosis
|PLoS ONE|2016|132
OSU-2S/Sorafenib Synergistic Antitumor Combination against Hepatocellular Carcinoma: The Role of PKCδ/p53
|Frontiers in Pharmacology|2016|30